Triterpenoid CDDO-EA Protects from Hyperglycemia, Hyperinsulinemia, and Obesity by Decreasing Energy Intake
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26125485 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Austin E Cantu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Baylor College of Medicine, Houston, TX 76798, USA. Hauptthemen laut MEDLINE: Obesity, Oleanolic Acid, Hyperglycemia, Hyperinsulinism. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Obesity is a significant factor in the development of type 2 diabetes (T2D). Treatment of obesity is pivotal in the prevention and management of T2D, and the development of new pharmacological therapies are studied for improving insulin resistance and glucose intolerance. Oleanolic acid-derived triterpenoids, 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acids (CDDOs), are studied to elucidate the mechanisms by which they protect against obesity. However, fundamental knowledge gaps remain regarding the physiological and molecular mechanisms by which CDDOs protect against obesity. Our recently published studies showed that CDDO-ethyl amide (CDDO-EA) prevents skeletal muscle inflammation by inhibiting activation of nuclear factor-kappa B (NF-κB) signaling. Moreover, CDDO-EA induced translocation of glucose transporter 4, GLUT4, in skeletal muscle cells. We hypothesized that CDDO-EA protects from obesity-induced hyperglycemia in mice fed a high-fat diet (HFD). Our results show that CDDO-EA protects from HFD-induced obesity but has no effect on body weight in mice fed a low-fat diet (LFD). Our data show that CDDO-EA inhibition of weight gain is associated with reduced caloric intake and glucose and insulin levels in mice fed an HFD. This highlights the potential of CDDO-EA as a therapeutic agent for obesity treatment and the protection against the development of T2D.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Baylor College of Medicine, Houston, TX 76798, USA.
- Department of Laboratory Animal Resources, The University of Texas Rio Grande Valley, Edinburg, TX 78539, USA.
- Department of Medical Education, School of Medicine, The University of Texas Rio Grande Valley, Edinburg, TX 78541, USA.
- School of Podiatric Medicine, The University of Texas Rio Grande Valley, Edinburg, TX 78539, USA.
- Division of Population Health and Biostatistics, School of Medicine, The University of Texas Rio Grande Valley, Edinburg, TX 78539, USA.
- Department of Translational Sciences, Graduate School of Biomedical Sciences, The University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA.
ORCID-Profile: Shizue Mito, Juan Carlos Lopez-Alvarenga, Sara M Reyna
Förderung
- NIGMS NIH HHS
- NIH HHS
- National Institutes of Health
- University of Texas Rio Grande Valley Faculty Research Seed Grant
- Institutional Seed Research Program Award
- Engaged Scholar and Artist Award
Zitieren
APA
Cantu, A. E., Rasa, C., Mito, S., Cantu, D., Lopez-Alvarenga, J. C., Rivera-Lopez, L. L., Rios, I., Abrego-Gonzalez, A., & Reyna, S. M. (2025). Triterpenoid CDDO-EA Protects from Hyperglycemia, Hyperinsulinemia, and Obesity by Decreasing Energy Intake. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26125485
Vancouver
Cantu AE, Rasa C, Mito S, Cantu D, Lopez-Alvarenga JC, Rivera-Lopez LL, et al. Triterpenoid CDDO-EA Protects from Hyperglycemia, Hyperinsulinemia, and Obesity by Decreasing Energy Intake. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26125485
BibTeX
@article{Cantu2025,
author = {Cantu, Austin E and Rasa, Cordelia and Mito, Shizue and Cantu, Denae and Lopez-Alvarenga, Juan Carlos and Rivera-Lopez, Leslie L and Rios, Israel and Abrego-Gonzalez, Ashley and Reyna, Sara M},
title = {Triterpenoid CDDO-EA Protects from Hyperglycemia, Hyperinsulinemia, and Obesity by Decreasing Energy Intake},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26125485}
}
EUVIMED